Humacyte to Participate at Upcoming Investor Conferences in May
Humacyte(HUMA) Newsfilter·2024-05-13 12:00DURHAM, N.C., May 13, 2024 (GLOBE NEWSWIRE) -- Humacyte, Inc. (NASDAQ:HUMA), a clinical-stage biotechnology platform company developing universally implantable, bioengineered human tissue at commercial scale, today announced that Laura Niklason, M.D., Ph.D., Founder, President, and Chief Executive Officer, Dale Sander, Chief Financial Officer, and B.J. Scheessele, Chief Commercial Officer, will represent Humacyte at the following conferences in May. H.C. Wainwright BioConnect Investor Conference at NASDAQ F ...